Margaret A. Honein

Margaret A. Honein's AcademicInfluence.com Rankings

Margaret A. Honein

Medical

#2665

World Rank

#3096

Historical Rank

Public Health

#403

World Rank

#416

Historical Rank

Epidemiology

#497

World Rank

#519

Historical Rank

medical Degrees

Download Badge

Medical

Margaret A. Honein's Degrees

PhD Epidemiology Emory University
Masters Public Health Emory University
Bachelors Biology University of Georgia

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Margaret A. Honein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Margaret A. Honein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Zika Virus. (2016) (2050)
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility (2020) (1797)
Zika Virus and Birth Defects--Reviewing the Evidence for Causality. (2016) (1665)
H1N1 2009 influenza virus infection during pregnancy in the USA (2009) (1100)
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington (2020) (1079)
Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. (2001) (1034)
Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020 (2020) (1015)
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. (2010) (872)
Maternal obesity and risk for birth defects. (2003) (642)
National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. (2006) (624)
Severe 2009 H1N1 influenza in pregnant and postpartum women in California. (2010) (563)
Temporal Trends in Survival Among Infants With Critical Congenital Heart Defects (2013) (429)
Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy (2017) (414)
COVID-19 in a Long-Term Care Facility — King County, Washington, February 27–March 9, 2020 (2020) (340)
Public Health Responses to COVID-19 Outbreaks on Cruise Ships — Worldwide, February–March 2020 (2020) (331)
Risk of bacterial meningitis in children with cochlear implants. (2003) (310)
COVID-19 Among Workers in Meat and Poultry Processing Facilities - 19 States, April 2020. (2020) (305)
Assisted reproductive technology and major structural birth defects in the United States. (2009) (290)
Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5–18, 2020 — 22 States, February–June 2020 (2020) (277)
Zika Virus Disease in Colombia - Preliminary Report. (2016) (270)
Use of over-the-counter medications during pregnancy. (2005) (268)
Maternal Smoking and Environmental Tobacco Smoke Exposure and the Risk of Orofacial Clefts (2007) (268)
Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016 (2017) (258)
A population‐based study of craniosynostosis in metropolitan Atlanta, 1989–2003 (2008) (249)
Maternal Smoking and Congenital Heart Defects (2008) (248)
Maternal age and non-chromosomal birth defects, Atlanta--1968-2000: teenager or thirty-something, who is at risk? (2004) (239)
Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy — U.S. Territories, January 1, 2016–April 25, 2017 (2017) (222)
Update: COVID-19 Among Workers in Meat and Poultry Processing Facilities ― United States, April–May 2020 (2020) (212)
Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection - United States, April-August 2009. (2009) (194)
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. (2016) (182)
Maternal treatment with opioid analgesics and risk for birth defects. (2011) (181)
Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020 (2021) (179)
Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromycin: a case review and cohort study (1999) (179)
Vital Signs: Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection — U.S. Territories and Freely Associated States, 2018 (2018) (174)
The National Birth Defects Prevention Study: A review of the methods. (2015) (166)
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. (2016) (163)
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020 (2020) (154)
Family history, maternal smoking, and clubfoot: an indication of a gene-environment interaction. (2000) (151)
Opioid Prescription Claims Among Women of Reproductive Age — United States, 2008–2012 (2015) (145)
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk (2013) (143)
Orofacial clefts in the National Birth Defects Prevention Study, 1997–2004 (2009) (143)
Racial differences in infant mortality attributable to birth defects in the United States, 1989-2002. (2006) (143)
Increasing Prevalence of Gastroschisis--14 States, 1995-2012. (2016) (140)
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure — United States (Including U.S. Territories), July 2017 (2017) (137)
Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009. (2009) (136)
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure--United States, 2016. (2016) (135)
Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure - United States, September 2016. (2016) (127)
Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports (2015) (127)
Severity of 2009 Pandemic Influenza A (H1N1) Virus Infection in Pregnant Women (2010) (127)
Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection — United States, October 2017 (2017) (124)
Preventing and Responding to COVID-19 on College Campuses. (2020) (121)
Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016. (2016) (119)
The Association Between Major Birth Defects and Preterm Birth (2009) (115)
Prolonged Detection of Zika Virus RNA in Pregnant Women (2016) (113)
Preliminary Report of Microcephaly Potentially Associated with Zika Virus Infection During Pregnancy - Colombia, January-November 2016. (2016) (112)
Spina bifida and anencephaly prevalence--United States, 1991-2001. (2002) (107)
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. (2016) (100)
Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review (2017) (98)
Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005. (2011) (96)
Maternal and infant outcomes among severely ill pregnant and postpartum women with 2009 pandemic influenza A (H1N1)--United States, April 2009-August 2010. (2011) (96)
Evaluation of selected characteristics of pregnancy drug registries. (1999) (95)
Children with Orofacial Clefts: Health-Care Use and Costs among a Privately Insured Population (2009) (95)
Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply. (2007) (93)
Sharing prescription medication among teenage girls: potential danger to unplanned/undiagnosed pregnancies. (2003) (90)
Priorities for Future Public Health Research in Orofacial Clefts (2007) (88)
Guidance for Implementing COVID-19 Prevention Strategies in the Context of Varying Community Transmission Levels and Vaccination Coverage (2021) (87)
Maternal periconceptional alcohol consumption and risk of orofacial clefts. (2007) (84)
Zika Virus Disease: A CDC Update for Pediatric Health Care Providers (2016) (81)
Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group. (2016) (80)
Birth defects surveillance: assessing the "gold standard". (1999) (80)
Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project. (2015) (80)
Estimated Number of Infants Detected and Missed by Critical Congenital Heart Defect Screening (2015) (79)
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture Workplaces (2020) (79)
Racial/ethnic differences in the birth prevalence of spina bifida - United States, 1995-2005. (2009) (78)
Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection--United States, February 2016. (2016) (74)
Health care expenditures for infants and young children with Down syndrome in a privately insured population. (2008) (74)
Trends in Number and Distribution of COVID-19 Hotspot Counties — United States, March 8–July 15, 2020 (2020) (73)
Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Men with Possible Zika Virus Exposure — United States, August 2018 (2018) (72)
Prescription medication borrowing and sharing among women of reproductive age. (2008) (71)
Pediatric inpatient hospital resource use for congenital heart defects. (2014) (71)
Maternal Thyroid Disease as a Risk Factor for Craniosynostosis (2007) (69)
Data and Policy to Guide Opening Schools Safely to Limit the Spread of SARS-CoV-2 Infection. (2021) (68)
Intent to become pregnant as a predictor of exposures during pregnancy: is there a relation? (2005) (68)
Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature. (2012) (67)
Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. (2009) (66)
Herbal use before and during pregnancy. (2010) (64)
Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? (2009) (62)
Population-Based Surveillance of Birth Defects Potentially Related to Zika Virus Infection — 15 States and U.S. Territories, 2016 (2018) (61)
Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases. (2011) (61)
Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak--Puerto Rico, 2016. (2016) (60)
Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study. (2008) (59)
Craniosynostosis and maternal smoking. (2008) (58)
Public Health Surveillance of Prenatal Opioid Exposure in Mothers and Infants (2019) (57)
Risk factors for non‐syndromic holoprosencephaly in the National Birth Defects Prevention Study (2010) (56)
Continued occurrence of Accutane-exposed pregnancies. (2001) (56)
Barriers to successful dietary control among pregnant women with phenylketonuria (2002) (56)
Bayesian Methods for Correcting Misclassification: An Example from Birth Defects Epidemiology (2009) (54)
Public Health Science Agenda for Congenital Heart Defects: Report From a Centers for Disease Control and Prevention Experts Meeting (2013) (52)
Maternal Smoking and Birth Defects: Validity of Birth Certificate Data for Effect Estimation (2001) (52)
COVID-19 Contact Tracing in Two Counties — North Carolina, June–July 2020 (2020) (52)
Maternal smoking and birth defects: validity of birth certificate data for effect estimation. (2001) (52)
Estimating the Number of Pregnant Women Infected With Zika Virus and Expected Infants With Microcephaly Following the Zika Virus Outbreak in Puerto Rico, 2016. (2016) (48)
Racial differences by gestational age in neonatal deaths attributable to congenital heart defects --- United States, 2003-2006. (2010) (48)
Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies. (2003) (48)
Fertility treatments and craniosynostosis: California, Georgia, and Iowa, 1993-1997. (2003) (48)
Maternal exposure to tobacco smoke, alcohol and caffeine, and risk of anorectal atresia: National Birth Defects Prevention Study 1997-2003. (2009) (47)
Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web‐based information, 2011 (2013) (46)
Antihistamines and birth defects: a systematic review of the literature (2014) (46)
Breast milk transmission of flaviviruses in the context of Zika virus: A systematic review (2018) (45)
Preventing Transmission of Zika Virus in Labor and Delivery Settings Through Implementation of Standard Precautions - United States, 2016. (2016) (44)
Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022 (2022) (44)
Projecting Month of Birth for At-Risk Infants after Zika Virus Disease Outbreaks (2016) (44)
Prenatal diagnosis of nonsyndromic congenital heart defects (2013) (44)
Possible Zika Virus Infection Among Pregnant Women - United States and Territories, May 2016. (2016) (43)
Priorities for public health research on craniosynostosis: Summary and recommendations from a Centers for Disease Control and Prevention‐sponsored meeting (2008) (42)
The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016–17 Zika virus outbreak (2018) (42)
Risk factors for isolated biliary atresia, National Birth Defects Prevention Study, 1997–2002 (2007) (42)
Zika Virus infection among U.S. pregnant travelers — August 2015–February 2016 (2016) (42)
Baseline Prevalence of Birth Defects Associated with Congenital Zika Virus Infection — Massachusetts, North Carolina, and Atlanta, Georgia, 2013–2014 (2017) (41)
Use of special education services by children with orofacial clefts. (2008) (41)
Evaluation of Placental and Fetal Tissue Specimens for Zika Virus Infection — 50 States and District of Columbia, January–December, 2016 (2017) (40)
Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015. (2016) (40)
Further evidence for an association between maternal smoking and craniosynostosis. (2000) (39)
Subfertility and prepregnancy overweight/obesity: possible interaction between these risk factors in the etiology of congenital renal anomalies. (2003) (38)
COVID-19 Case Investigation and Contact Tracing Efforts from Health Departments — United States, June 25–July 24, 2020 (2021) (38)
Response to Importation of a Case of Ebola Virus Disease — Ohio, October 2014 (2014) (37)
Serial Head and Brain Imaging of 17 Fetuses With Confirmed Zika Virus Infection in Colombia, South America. (2017) (37)
Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997–2007 (2013) (36)
Can We Ensure the Safe Use of Known Human Teratogens? (2007) (32)
Rapid Diagnostic Testing for Response to the Monkeypox Outbreak — Laboratory Response Network, United States, May 17–June 30, 2022 (2022) (32)
Zika Virus Disease and Pregnancy Outcomes in Colombia. (2020) (31)
Racial and ethnic disparity in participation in DNA collection at the Atlanta site of the National Birth Defects Prevention Study. (2006) (31)
Maternal caffeine intake during pregnancy and orofacial clefts. (2009) (30)
State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome (2019) (29)
Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States (2011) (28)
Alcohol Use and Co-Use of Other Substances Among Pregnant Females Aged 12–44 Years — United States, 2015–2018 (2020) (28)
Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997-2004. (2010) (27)
Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. (2016) (27)
Prenatal diagnosis of orofacial clefts, National Birth Defects Prevention Study, 1998–2004 (2009) (26)
Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk (2014) (26)
Zika Virus -10 Public Health Achievements in 2016 and Future Priorities. (2017) (26)
Modeling the potential public health impact of prepregnancy obesity on adverse fetal and infant outcomes (2013) (26)
Zika Virus Disease in Children in Colombia, August 2015 to May 2016 (2017) (25)
Maternal attitudes toward DNA collection for gene–environment studies: A qualitative research study (2009) (25)
Proportion of selected congenital heart defects attributable to recognized risk factors. (2016) (25)
Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects. (2013) (24)
Potential Sensitivity of Bias Analysis Results to Incorrect Assumptions of Nondifferential or Differential Binary Exposure Misclassification (2014) (24)
Racial/Ethnic Differences in Infant Mortality Attributable to Birth Defects by Gestational Age (2012) (23)
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meeting. (2014) (23)
Measures Taken to Prevent Zika Virus Infection During Pregnancy — Puerto Rico, 2016 (2017) (22)
Updated baseline prevalence of birth defects potentially related to Zika virus infection (2019) (22)
CDC Grand Rounds: Understanding the Causes of Major Birth Defects - Steps to Prevention. (2015) (22)
Recognizing the Global Impact of Zika Virus Infection during Pregnancy. (2018) (21)
Racial and Ethnic Disparities in Fetal Deaths — United States, 2015–2017 (2020) (21)
A Preparedness Model for Mother–Baby Linked Longitudinal Surveillance for Emerging Threats (2020) (20)
Assessment of risk factors for infantile cataracts using a case-control study: National Birth Defects Prevention Study, 2000-2004. (2010) (20)
Periconceptional use of weight loss products including ephedra and the association with birth defects. (2008) (20)
Assessment of Current Practices and Feasibility of Routine Screening for Critical Congenital Heart Defects — Georgia, 2012 (2013) (20)
Birth Defects Potentially Related to Zika Virus Infection During Pregnancy in the United States. (2018) (20)
Can We Ensure the Safe Use of Known Human Teratogens? (2004) (19)
Screening for SARS-CoV-2 Infection Within a Psychiatric Hospital and Considerations for Limiting Transmission Within Residential Psychiatric Facilities — Wyoming, 2020 (2020) (19)
Methods for a public health response to birth defects clusters. (2002) (19)
Public Health Approach to Improve Outcomes for Congenital Heart Disease Across the Life Span (2019) (18)
The need for safer medication use in pregnancy (2013) (18)
Population-based study of hospital costs for hospitalizations of infants, children, and adults with a congenital heart defect, Arkansas 2006 to 2011. (2015) (17)
Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM). (2011) (17)
Adjusting for bias due to incomplete case ascertainment in case-control studies of birth defects. (2015) (17)
Reported multivitamin consumption and the occurrence of multiple congenital anomalies (2005) (16)
Serologic evidence of respiratory and rickettsial infections among Somali refugees. (1995) (16)
Prevention of orofacial clefts caused by smoking: implications of the Surgeon General's report. (2014) (16)
Surveillance for Emerging Threats to Pregnant Women and Infants. (2018) (15)
Evaluation of mailed pediatric buccal cytobrushes for use in a case-control study of birth defects. (2011) (14)
Severe Influenza Among Children and Young Adults with Neurologic and Neurodevelopmental Conditions — Ohio, 2011 (2012) (14)
A pilot study using residual newborn dried blood spots to assess the potential role of cytomegalovirus and Toxoplasma gondii in the etiology of congenital hydrocephalus. (2013) (13)
Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study (2008) (13)
Estimating the numbers of pregnant women infected with Zika virus and infants with congenital microcephaly in Colombia, 2015-2017. (2018) (13)
CDC Deployments to State, Tribal, Local, and Territorial Health Departments for COVID-19 Emergency Public Health Response — United States, January 21–July 25, 2020 (2020) (12)
Zika Virus. (2020) (12)
Continued occurrence of accutane® -exposed pregnancies (2002) (12)
Time from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes — 17 States, June–October 2020 (2021) (12)
Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students (2021) (11)
Zika Virus Detection in Amniotic Fluid and Zika-Associated Birth Defects. (2020) (11)
Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 (2022) (11)
Monitoring and Preventing Congenital Zika Syndrome. (2016) (11)
Population-Based Surveillance for Birth Defects Potentially Related to Zika Virus Infection — 22 States and Territories, January 2016–June 2017 (2020) (10)
Population-based pregnancy and birth defects surveillance in the era of Zika virus. (2017) (10)
Comparison of Two Case Definitions for Ascertaining Prevalence of Autism Spectrum Disorder among 8-Year-Old Children. (2021) (10)
Qualitative assessment of study materials and communication strategies used in studies that include DNA collection (2011) (10)
Periconceptional consumption of vitamins containing folic acid and risk for multiple congenital anomalies (2007) (9)
Community Understanding of Contraception During the Zika Virus Outbreak in Puerto Rico (2020) (9)
Protecting Mothers and Babies - A Delicate Balancing Act. (2018) (9)
Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection — U.S. Zika Pregnancy and Infant Registry, December 1, 2015–March 31, 2018 (2022) (9)
CDC Pregnancy Flu Line: Monitoring Severe Illness Among Pregnant Women with Influenza (2014) (9)
Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020 (2021) (8)
Limitations, depressive symptoms, and quality of life among a population-based sample of young adults with congenital heart defects. (2016) (7)
Neurodevelopmental findings in children 20-30 months of age with postnatal Zika infection at 1-12 months of age, Colombia, September-November 2017. (2020) (7)
Transmission Dynamics of Severe Acute Respiratory Syndrome Coronavirus 2 in High-Density Settings, Minnesota, USA, March–June 2020 (2021) (7)
Pregnancy and H1N1 infection – Authors' reply (2009) (7)
Neurodevelopmental Abnormalities Associated With In Utero Zika Virus Infection in Infants and Children-The Unfolding Story. (2020) (7)
Revealing the Effects of Zika-Detection of Brain Abnormalities and Other Disabilities Associated With Congenital Infection. (2019) (6)
Using Supervised Learning Methods to Develop a List of Prescription Medications of Greatest Concern during Pregnancy (2020) (6)
The eyes as a window to improved understanding of the prenatal effects of Zika virus infection. (2017) (6)
Community Perspectives on Contraception in the Context of the Zika Virus in the U.S. Virgin Islands: Implications for Communication and Messaging. (2019) (6)
Problems with informing women adequately about teratogen risk: some barriers to preventing exposures to known teratogens. (2002) (6)
Epidemiology of cytomegalovirus Infection among mothers and infants in Colombia (2021) (6)
Signs, Symptoms, and Comorbidities Associated with Poor Outcomes among Residents of a Skilled Nursing Facility with SARS-CoV-2 Infection—King County, Washington (2021) (6)
Protecting Mothers and Babies: A Delicate Balancing Act (2019) (5)
Endemic Zika virus transmission: implications for travellers. (2019) (5)
Letter to the editor: Ventricular septal defects and the National Birth Defects Prevention Study. (2011) (5)
Assessment of Contraceptive Use in Puerto Rico during the 2016 Zika Virus Outbreak. (2020) (5)
Health Care Autonomy of Women Living with HIV. (2019) (5)
Pregnancy, Birth, Infant, and Early Childhood Neurodevelopmental Outcomes among a Cohort of Women with Symptoms of Zika Virus Disease during Pregnancy in Three Surveillance Sites, Project Vigilancia de Embarazadas con Zika (VEZ), Colombia, 2016–2018 (2021) (5)
Etiology of Microcephaly and Central Nervous System Defects during the Zika Epidemic in Colombia. (2020) (5)
Identifying Co-Exposure to Opiates and Gabapentin During Pregnancy. (2020) (5)
Public Health Approach to Decrease Mortality for Congenital Heart Defects: Dying Too Soon. (2018) (5)
Cost-Effectiveness of Oral Isotretinoin (1999) (4)
H1N1 2009 Influenza Virus Infection During Pregnancy in the United States (2010) (4)
Mass SARS-CoV-2 Testing in a Dormitory-Style Correctional Facility in Arkansas. (2021) (4)
A model partnership for communication and dissemination of scientific recommendations for pregnant women during the emergency response to the Zika virus outbreak: MotherToBaby and the Centers for Disease Control and Prevention (2020) (4)
Signs, Symptoms, and Comorbidities Associated With Onset and Prognosis of COVID-19 in a Nursing Home (2021) (4)
Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects (2020) (3)
Maternal body mass index as a risk factor for craniosynostosis (2010) (3)
Factors associated with inpatient hospitalizations among patients aged 1 to 64 years with congenital heart defects, Arkansas 2006 to 2011. (2015) (3)
The Role of Testing in Reducing SARS-CoV-2 Transmission on College Campuses (2020) (3)
Opioid prescription claims among women aged 15-44 years-United States, 2013-2017. (2021) (2)
Balancing competing risks: perinatal exposure to macrolides increases the risk of infantile hypertrophic pyloric stenosis (2014) (2)
Evaluating Differences in Whole Blood, Serum, and Urine Screening Tests for Zika Virus, Puerto Rico, USA, 2016 (2021) (2)
The safety or risk of antihistamine use in pregnancy: reassuring data are helpful but not sufficient. (2013) (2)
Maternal periconceptional alcohol consumption and risks for orofacial clefts (1999) (2)
Zika virus as a cause of birth defects: Were the teratogenic effects of Zika virus missed for decades? (2022) (2)
Evaluation of selected characteristics of pregnancy drug registriesThis article is a US Government work and, as such, is in the public domain in the United States of America. (1999) (2)
Cohort profile: congenital Zika virus infection and child neurodevelopmental outcomes in the ZEN cohort study in Colombia (2020) (2)
Reply: ART and major structural birth defects in the USA (2009) (2)
Clinical phenotype in infants with negative Zika virus immunoglobulin M testing born to mothers with confirmed Zika virus infection during pregnancy (2021) (1)
Identifying possible inaccuracy in reported birth head circumference measurements among infants in the US Zika Pregnancy and Infant Registry (2021) (1)
Abstract 18716: Survival for Infants with Critical Congenital Heart Defects in Atlanta, Georgia, 1979-2005: Temporal Trends and Prognostic Factors (2012) (1)
Reviewers for the Journal, January-June 2016. (2016) (1)
Zika Prevention Behaviors Among Women of Reproductive Age in Puerto Rico, 2016. (2021) (1)
Influenza-Like Illness Among Personnel Responding to U.S. Quarantine of Cruise Ship Passengers Exposed to SARS-CoV-2 (2021) (1)
SAFETY OF CONTRACEPTIVE USE AMONG WOMEN WITH CONGENITAL HEART DISEASE: A SYSTEMATIC REVIEW (2016) (1)
Assessment of Neonatal Abstinence Syndrome Surveillance — Pennsylvania, 2019 (2021) (1)
HOSPITAL RESOURCE USE FOR CRITICAL CONGENITAL HEART DEFECT PEDIATRIC ADMISSIONS (2013) (1)
Impact of Folic Acid Fortification on Orofacial Clefts (2006) (1)
Evaluation of self-administered antigen testing in a college setting (2022) (1)
Testing for SARS-CoV-2 among cruise ship travelers repatriated to the United States, February to March 2020 (2021) (1)
The Safety of Asthma Medications during Pregnancy and Lactation: Clinical Management and Research Priorities. (2021) (1)
Plague and Pregnancy: Why Special Considerations Are Needed. (2020) (1)
Responding to the Threat Posed by Anthrax: Updated Evidence to Improve Preparedness. (2022) (1)
Impact of sample collection participation on the validity of estimated measures of association in the National Birth Defects Prevention Study when assessing gene‐environment interactions (2017) (1)
Zika Pregnancy Surveillance: Transforming Data into Educational and Clinical Tools (2019) (0)
CDC Zika IMS Jurisdiction and Partner Sustainment Strategy : Wednesday, March 1, 2017 (2017) (0)
Zika: Evolution of Diagnostics and Neurodevelopmental Outcome in Congenital Zika Infection (2018) (0)
Abstract 305: Trends in and Risk Factors Affecting Survival for Infants with Critical Congenital Heart Disease: Atlanta, Georgia, 1979-2005 (2012) (0)
PERIPARTUM HYSTERECTOMY IN THE UNITED STATES– IMPACT OF FOLIC ACID FORTIFICATION ON OROFACIAL PERIODONTAL DISEASE AND GESTATIONAL DIABETES MYCOPLASMA GENITALIUM IS ASSOCIATED WITH PERSISTENT AND RECURRENT PELVIC INFLAMMATORY DISEASE. (2017) (0)
Prepregnancy body mass index and spina bifida: Potential contributions of bias (2021) (0)
NBDPN 2008: Advances and Opportunities for Birth Defects Surveillance, Research, & Prevention Category 1: Case Ascertainment- Innovative Approaches, Use of Physician Office Data, Prenatal Surveillance, Pediatric Cardiac Registries, Record Linkage C1.1 Arizona Birth Defects Monitoring Program Changin (2008) (0)
Utilization of Whole Genome Sequencing to Understand SARS-CoV-2 Transmission Dynamics in Long-Term Care Facilities, Correctional Facilities and Meat Processing Plants in Minnesota, March - June 2020 (2021) (0)
103: Risk factors for infantile cataracts, national birth defects prevention study, 2000-2004 (2009) (0)
460: Reported Multivitamin Consumption and Multiple Congenital Anomalies (2005) (0)
Maternal obesity and abdominal wall defects (2001) (0)
Subject Index Vol. 198, 1999 (1999) (0)
The STREAM trial: missed opportunities and lessons for future clinical trials (2019) (0)
Risk Factors for Infantile Cataracts, 2000-2003 (2007) (0)
Health Care Utilization And Costs Among Privately Insured Children With Orofacial Clefts (2014) (0)
Racial Disparities in Infant Mortality Due to Birth Defects (2006) (0)
Prenatal Diagnosis of Non-Syndromic Congenital Heart Defects (2015) (0)
194: Assisted Reproductive Techniques and Selected Major Birth Defects. Data from the NBDPS, 1997–2001 (2005) (0)
Prevalence of congenital CMV infection in Colombia (2019) (0)
Better surveillance to protect mothers and infants from Zika. (2019) (0)
Pregnancy-intendedness and lifestyle factors: is there a relation? (2001) (0)
Zika virus knowledge, attitudes and prevention behaviors among pregnant women in the ZEN cohort study, Colombia, 2017-2018. (2023) (0)
Contents Vol. 198, 1999 (1999) (0)
Prenatal versus postnatal repair of myelomeningocele. (2011) (0)
Severe Necrotizing Pneumonia in Children, Houston, Texas, USA (2009) (0)
Zika Virus Infection in Pregnancy (2017) (0)
Prevalence of individual brain and eye defects potentially related to Zika virus in pregnancy in 22 U.S. states and territories, January 2016 to June 2017 (2022) (0)
Appendix D. Use of contraception at last sexual intercourse by race/ethnicity among female students in grades 9-12 who were currently sexually active* — selected states where mosquito-borne transmission may be possible, Youth Risk Behavior Survey (YRBS), 2015 (2016) (0)
84. Clarifying the Congenital Zika Syndrome Phenotype and Expanding to Congenital Zika Spectrum in the Absence of Laboratory Evidence (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Margaret A. Honein?

Margaret A. Honein is affiliated with the following schools:

Emory University
University of Washington
University of Georgia

Margaret A. Honein's Academic­Influence.com Rankings

Margaret A. Honein's Degrees

Similar Degrees You Can Earn

Why Is Margaret A. Honein Influential?

Margaret A. Honein's Published Works

Published Works

What Schools Are Affiliated With Margaret A. Honein?

Margaret A. Honein's AcademicInfluence.com Rankings